{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:21:48Z","timestamp":1791951708040,"version":"4.3.4"},"reference-count":480,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"FWO \u2013 Flanders"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.1093\/europace\/euac030","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:11:54Z","timestamp":1649059914000},"page":"1307-1367","source":"Crossref","is-referenced-by-count":349,"title":["European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases"],"prefix":"10.1093","volume":"24","author":[{"given":"Arthur A M","family":"Wilde","sequence":"first","affiliation":[{"name":"Heart Centre, Department of Cardiology, Amsterdam Universitair Medische Centra , Amsterdam, location AMC ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Semsarian","sequence":"additional","affiliation":[{"name":"Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, University of Sydney , Sydney ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlio F","family":"M\u00e1rquez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez, Ciudad de M\u00e9xico ,","place":["Mexico"]},{"name":"Member of the Latin American Heart Rhythm Society (LAHRS)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza Sepehri","family":"Shamloo","sequence":"additional","affiliation":[{"name":"Department of Electrophysiology, Heart Center at University of Leipzig , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Departments of Cardiovascular Medicine, Pediatric and Adolescent Medicine, and Molecular Pharmacology & Experimental Therapeutics; Divisions of Heart Rhythm Services and Pediatric Cardiology; Windland Smith Rice Genetic Heart Rhythm Clinic and Windland Smith Rice Sudden Death Genomics Laboratory , Mayo Clinic, Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euan A","family":"Ashley","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Stanford University , Stanford, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Back","family":"Sternick","sequence":"additional","affiliation":[{"name":"Arrhythmia and Electrophysiology Unit, Biocor Institute , Minas Gerais , ; and Member of the Latin American Heart Rhythm Society (LAHRS)","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Barajas-Martinez","sequence":"additional","affiliation":[{"name":"Cardiovascular Research, Lankenau Institute of Medical Research , Wynnewood, PA , ; and Member of the Latin American Heart Rhythm Society (LAHRS)","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah R","family":"Behr","sequence":"additional","affiliation":[{"name":"Cardiovascular Clinical Academic Group, Institute of Molecular and Clinical Sciences, St. George\u2019s, University of London; St. George\u2019s University Hospitals NHS Foundation Trust , London , ; Mayo Clinic Healthcare, London","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie R","family":"Bezzina","sequence":"additional","affiliation":[{"name":"Amsterdam UMC Heart Center, Department of Experimental Cardiology , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Breckpot","sequence":"additional","affiliation":[{"name":"Center for Human Genetics, University Hospitals Leuven , Leuven ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, APHP, Centre de R\u00e9f\u00e9rence des Maladies Cardiaques H\u00e9r\u00e9ditaires , ICAN, Inserm UMR1166, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Chockalingam","sequence":"additional","affiliation":[{"name":"Cardiac Wellness Institute , Chennai ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Crotti","sequence":"additional","affiliation":[{"name":"Center for Cardiac Arrhythmias of Genetic Origin , Istituto Auxologico Italiano, IRCCS, Milan ,","place":["Italy"]},{"name":"Cardiomyopathy Unit and Cardiac Rehabilitation Unit, San Luca Hospital, Istituto Auxologico Italiano, IRCCS , Milan ,","place":["Italy"]},{"name":"Department of Medicine and Surgery, University of Milano-Bicocca , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Gollob","sequence":"additional","affiliation":[{"name":"Inherited Arrhythmia and Cardiomyopathy Program, Division of Cardiology, University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lubitz","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Service, Massachusetts General Hospital and Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomasa","family":"Makita","sequence":"additional","affiliation":[{"name":"National Cerebral and Cardiovascular Center, Research Institute , Suita ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center , Suita ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Ortiz-Genga","sequence":"additional","affiliation":[{"name":"Clinical Department , Health in Code, A Coru\u00f1a , ; and Member of the Latin American Heart Rhythm Society (LAHRS)","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Sacilotto","sequence":"additional","affiliation":[{"name":"Arrhythmia Unit, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo , Sao Paulo , ; and Member of the Latin American Heart Rhythm Society (LAHRS)","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Schulze-Bahr","sequence":"additional","affiliation":[{"name":"Institute for Genetics of Heart Diseases, University Hospital M\u00fcnster , M\u00fcnster ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Nippon Medical School , Bunkyo-ku, Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nona","family":"Sotoodehnia","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit, Division of Cardiology, Department of Medicine, University of Washington , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik","family":"Tadros","sequence":"additional","affiliation":[{"name":"Cardiovascular Genetics Center, Department of Medicine, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al , Montreal ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S","family":"Ware","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute and MRC London Institute of Medical Sciences, Imperial College London , London ,","place":["UK"]},{"name":"Royal Brompton & Harefield Hospitals , Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust, London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Winlaw","sequence":"additional","affiliation":[{"name":"Cincinnati Children's Hospital Medical Centre, University of Cincinnati , Cincinnati, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Metrohealth Medical Center, Case Western Reserve University , Cleveland, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Document Reviewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Aiba","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine and Genetics, National Cerebral and Cardiovascular Center , Suita, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bollmann","sequence":"additional","affiliation":[{"name":"Department of Electrophysiology, Heart Center Leipzig at University of Leipzig , Leipzig ,","place":["Germany"]},{"name":"Leipzig Heart Institute , Leipzig Heart Digital, Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Il","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Dalal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Cardiology, Vanderbilt University School of Medicine , Nashville, TN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Darrieux","sequence":"additional","affiliation":[{"name":"Arrhythmia Unit, Instituto do Cora\u00e7\u00e3o, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina, Universidade de S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Giudicessi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine (Divisions of Heart Rhythm Services and Circulatory Failure and the Windland Smith Rice Genetic Heart Rhythm Clinic) , Mayo Clinic, Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Guerchicoff","sequence":"additional","affiliation":[{"name":"Division of Pediatric Arrhythmia and Electrophysiology, Italian Hospital of Buenos Aires , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University , Nanchang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Krahn","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of British Columbia , Vancouver ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciorsti","family":"MacIntyre","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Division of Heart Rhythm Services , Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A","family":"Mackall","sequence":"additional","affiliation":[{"name":"Center for Cardiac Electrophysiology and Pacing, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine , Cleveland, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Mont","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi Sunyer (IDIBAPS) \u00a0 Barcelona ,","place":["Spain"]},{"name":"Centro de Investigacion Biomedica en Red en Enfermedades Cardiovasculares (CIBERCV) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Molecular Cardiology, Istituti Clinici Scientifici Maugeri , IRCCS, Pavia ,","place":["Italy"]},{"name":"Department of Molecular Medicine, University of Pavia , Pavia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Ochoa","sequence":"additional","affiliation":[{"name":"Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) , Madrid ,","place":["Spain"]},{"name":"Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro , Madrid ,","place":["Spain"]},{"name":"Centro de Investigacion Biomedica en Red en Enfermedades Cariovasculares (CIBERCV) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Peichl","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute for Clinical and Experimental Medicine , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre C","family":"Pereira","sequence":"additional","affiliation":[{"name":"Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of S\u00e3o Paulo Medical School , S\u00e3o Paulo 05403-000 ,","place":["Brazil"]},{"name":"Hipercol Brasil Program , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Center for Cardiac Arrhythmias of Genetic Origin , Istituto Auxologico Italiano, IRCCS, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Skinner","sequence":"additional","affiliation":[{"name":"Sydney Childrens Hospital Network, University of Sydney , Sydney ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Intensive Care Medicine, University Hospital Campus Klinikum Bielefeld , Bielefeld ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Tfelt-Hansen","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, the Heart Centre, Copenhagen University Hospital , Rigshopitalet, Copenhagen ,","place":["Denmark"]},{"name":"Section of genetics, Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Deneke","sequence":"additional","affiliation":[{"name":"Heart Center Bad Neustadt , Bad Neustadt a.d. Saale ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Developed in partnership with and endorsed by the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"2026080912175992400_euac030-B1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B2","first-page":"3925","article-title":"Jr. Modifier genes for sudden cardiac death","volume":"39","author":"Schwartz","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B3","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1093\/eurheartj\/ehaa269","article-title":"When genetic burden reaches threshold","volume":"41","author":"Walsh","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/euhj.1999.1677","article-title":"Task Force Report: the legal implications of medical guidelines\u2014a Task Force of the European Society of Cardiology","volume":"20","author":"Schwartz","year":"1999","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2020.10.010","article-title":"2020 APHRS\/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families","volume":"18","author":"Stiles","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/joa3.12264","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary","volume":"36","author":"Cronin","year":"2020","journal-title":"J Arrhythm"},{"key":"2026080912175992400_euac030-B8","doi-asserted-by":"crossref","first-page":"e000067","DOI":"10.1161\/HCG.0000000000000067","article-title":"Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association","volume":"13","author":"Musunuru","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41431-019-0445-y","article-title":"European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death","volume":"27","author":"Fellmann","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"2026080912175992400_euac030-B10","doi-asserted-by":"crossref","first-page":"e002460","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the clinical validity of hypertrophic cardiomyopathy genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B11","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.hrthm.2019.09.019","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B12","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B13","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B14","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/j.hrthm.2014.07.024","article-title":"EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias","volume":"11","author":"Pedersen","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B15","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B16","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","article-title":"Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"31","author":"Charron","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B17","article-title":"A multi-centred, evidence-based evaluation of gene validity in sudden arrhythmic death syndromes: CPVT and the short QT syndrome","author":"Walsh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B18","doi-asserted-by":"crossref","first-page":"e003273","DOI":"10.1161\/CIRCGEN.120.003273","article-title":"International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework","volume":"14","author":"James","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-based assessment of genes in dilated cardiomyopathy","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.119.043132","article-title":"An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome","volume":"141","author":"Adler","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.118.035070","article-title":"Reappraisal of reported genes for sudden arrhythmic death: evidence-based evaluation of gene validity for Brugada syndrome","volume":"138","author":"Hosseini","year":"2018","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/2047487316676042","article-title":"Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE","volume":"24","author":"Mont","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2026080912175992400_euac030-B23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","article-title":"A brief history of human disease genetics","volume":"577","author":"Claussnitzer","year":"2020","journal-title":"Nature"},{"key":"2026080912175992400_euac030-B24","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jacc.2012.12.054","article-title":"Genomics in cardiovascular disease","volume":"61","author":"Roberts","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.109.914804","article-title":"Impact of genetic insights into mendelian disease on cardiovascular clinical practice","volume":"123","author":"Kim","year":"2011","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/eurheartj\/ehq067","article-title":"DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model","volume":"31","author":"Wordsworth","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nrcardio.2013.108","article-title":"Genetic testing for inherited cardiac disease","volume":"10","author":"Wilde","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"2026080912175992400_euac030-B28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.120.045956","article-title":"Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome","volume":"142","author":"Lahrouchi","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41588-020-00762-2","article-title":"Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect","volume":"53","author":"Tadros","year":"2021","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ng.862","article-title":"Variation in genome-wide mutation rates within and between human families","volume":"43","author":"Conrad","year":"2011","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"key":"2026080912175992400_euac030-B33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/35066065","article-title":"To err (meiotically) is human: the genesis of human aneuploidy","volume":"2","author":"Hassold","year":"2001","journal-title":"Nat Rev Genet"},{"key":"2026080912175992400_euac030-B34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1136678","article-title":"Relative impact of nucleotide and copy number variation on gene expression phenotypes","volume":"315","author":"Stranger","year":"2007","journal-title":"Science"},{"key":"2026080912175992400_euac030-B35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.genom.9.081307.164217","article-title":"Copy number variation in human health, disease, and evolution","volume":"10","author":"Zhang","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2026080912175992400_euac030-B36","first-page":"1721","article-title":"[Study of somatic chromosomes from 9 mongoloid children]","volume":"248","author":"Lejeune","year":"1959","journal-title":"C R Hebd Seances Acad Sci"},{"key":"2026080912175992400_euac030-B37","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026080912175992400_euac030-B38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","author":"International Human Genome Sequencing Consortium","year":"2004","journal-title":"Nature"},{"key":"2026080912175992400_euac030-B39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature03959","article-title":"Genome sequencing in microfabricated high-density picolitre reactors","volume":"437","author":"Margulies","year":"2005","journal-title":"Nature"},{"key":"2026080912175992400_euac030-B40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature07517","article-title":"Accurate whole human genome sequencing using reversible terminator chemistry","volume":"456","author":"Bentley","year":"2008","journal-title":"Nature"},{"key":"2026080912175992400_euac030-B41","doi-asserted-by":"crossref","first-page":"19096","DOI":"10.1073\/pnas.0910672106","article-title":"Genetic diagnosis by whole exome capture and massively parallel DNA sequencing","volume":"106","author":"Choi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026080912175992400_euac030-B42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature08250","article-title":"Targeted capture and massively parallel sequencing of 12 human exomes","volume":"461","author":"Ng","year":"2009","journal-title":"Nature"},{"key":"2026080912175992400_euac030-B43","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddv259","article-title":"Non-coding genetic variants in human disease","volume":"24","author":"Zhang","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2026080912175992400_euac030-B44","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/s41467-019-10717-9","article-title":"Characterising the loss-of-function impact of 5' untranslated region variants in 15,708 individuals","volume":"11","author":"Whiffin","year":"2020","journal-title":"Nat Commun"},{"key":"2026080912175992400_euac030-B45","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41467-018-08148-z","article-title":"Multi-platform discovery of haplotype-resolved structural variation in human genomes","volume":"10","author":"Chaisson","year":"2019","journal-title":"Nat Commun"},{"key":"2026080912175992400_euac030-B46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrg2958","article-title":"Genome structural variation discovery and genotyping","volume":"12","author":"Alkan","year":"2011","journal-title":"Nat Rev Genet"},{"key":"2026080912175992400_euac030-B47","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nmeth.2633","article-title":"Absolute quantification by droplet digital PCR versus analog real-time PCR","volume":"10","author":"Hindson","year":"2013","journal-title":"Nat Methods"},{"key":"2026080912175992400_euac030-B48","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1093\/nar\/gkp552","article-title":"Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances","volume":"37","author":"LaFramboise","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2026080912175992400_euac030-B49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B50","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"10 years of GWAS discovery: biology, function, and translation","volume":"101","author":"Visscher","year":"2017","journal-title":"Am J Hum Genet"},{"key":"2026080912175992400_euac030-B52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/gepi.20303","article-title":"Estimation of the multiple testing burden for genomewide association studies of nearly all common variants","volume":"32","author":"Pe'er","year":"2008","journal-title":"Genet Epidemiol"},{"key":"2026080912175992400_euac030-B53","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ng.716","article-title":"Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction","volume":"42","author":"Sotoodehnia","year":"2010","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B54","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/CIRCULATIONAHA.119.041161","article-title":"Genome-wide analysis of left ventricular image-derived phenotypes identifies fourteen loci associated with cardiac morphogenesis and heart failure development","volume":"140","author":"Aung","year":"2019","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41588-018-0303-9","article-title":"Trans-ethnic association study of blood pressure determinants in over 750,000 individuals","volume":"51","author":"Giri","year":"2019","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B56","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat Commun"},{"key":"2026080912175992400_euac030-B58","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41588-018-0133-9","article-title":"Multi-ethnic genome-wide association study for atrial fibrillation","volume":"50","author":"Roselli","year":"2018","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B59","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1093\/eurheartj\/ehy474","article-title":"A comprehensive evaluation of the genetic architecture of sudden cardiac arrest","volume":"39","author":"Ashar","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B60","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ng.2712","article-title":"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death","volume":"45","author":"Bezzina","year":"2013","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B61","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","article-title":"A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy","volume":"32","author":"Villard","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B62","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B63","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/CIRCULATIONAHA.119.043805","article-title":"Predicting benefit from evolocumab therapy in patients with atherosclerotic disease using a genetic risk score: results from the FOURIER trial","volume":"141","author":"Marston","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B64","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.119.044434","article-title":"Patients with high genome-wide polygenic risk scores for coronary artery disease may receive greater clinical benefit from alirocumab treatment in the ODYSSEY OUTCOMES trial","volume":"141","author":"Damask","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B65","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.120.046397","article-title":"The effect of PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) inhibition on the risk of venous thromboembolism","volume":"141","author":"Marston","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B66","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/eurheartj\/ehz435","article-title":"Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores","volume":"40","author":"Tadros","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B67","doi-asserted-by":"crossref","first-page":"e002911","DOI":"10.1161\/CIRCGEN.120.002911","article-title":"SCN5A mutation type and a genetic risk score associate variably with Brugada syndrome phenotype in SCN5A families","volume":"13","author":"Wijeyeratne","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B68","doi-asserted-by":"crossref","first-page":"e002922","DOI":"10.1161\/CIRCGEN.120.002922","article-title":"Corrected QT interval-polygenic risk score and its contribution to type 1, type 2, and type 3 long-QT syndrome in probands and genotype-positive family members","volume":"13","author":"Turkowski","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B70","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMsa1507092","article-title":"Genetic misdiagnoses and the potential for health disparities","volume":"375","author":"Manrai","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B71","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4065\/78.12.1479","article-title":"Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome","volume":"78","author":"Ackerman","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"2026080912175992400_euac030-B72","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.hrthm.2004.07.013","article-title":"Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada\/long QT syndrome genetic testing","volume":"1","author":"Ackerman","year":"2004","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B73","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/CIRCULATIONAHA.117.030142","article-title":"Classification and reporting of potentially proarrhythmic common genetic variation in long QT syndrome genetic testing","volume":"137","author":"Giudicessi","year":"2018","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B74","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tcm.2018.03.003","article-title":"The genetic architecture of long QT syndrome: a critical reappraisal","volume":"28","author":"Giudicessi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"2026080912175992400_euac030-B75","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.mayocp.2016.08.008","article-title":"The Promise and Peril of Precision Medicine","volume":"91","author":"Ackerman","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2026080912175992400_euac030-B76","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gim.2017.218","article-title":"Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel","volume":"20","author":"Kelly","year":"2018","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B77","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41436-021-01107-y","article-title":"Clinical and laboratory reporting impact of ACMG-AMP and modified ClinGen variant classification frameworks in MYH7-related cardiomyopathy","volume":"23","author":"Richmond","year":"2021","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B78","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.hrthm.2021.11.017","article-title":"A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome","volume":"19","author":"Bains","year":"2022","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B79","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3343\/alm.2019.39.5.421","article-title":"Challenges and considerations in sequence variant interpretation for mendelian disorders","volume":"39","author":"Kim","year":"2019","journal-title":"Ann Lab Med"},{"key":"2026080912175992400_euac030-B80","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/gim.2018.3","article-title":"ClinGen's RASopathy Expert Panel consensus methods for variant interpretation","volume":"20","author":"Gelb","year":"2018","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","article-title":"Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives","volume":"60","author":"Maron","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B82","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehz396","article-title":"Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines?","volume":"40","author":"Lafreniere-Roula","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B83","doi-asserted-by":"crossref","first-page":"e001916","DOI":"10.1161\/CIRCGENETICS.117.001916","article-title":"Pathogenicity of hypertrophic cardiomyopathy variants: a path forward together","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B84","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/cge.13024","article-title":"Clinical genetic testing in pediatric cardiomyopathy: is bigger better?","volume":"93","author":"Ouellette","year":"2018","journal-title":"Clin Genet"},{"key":"2026080912175992400_euac030-B85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.111.090514","article-title":"Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing","volume":"127","author":"Jensen","year":"2013","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B86","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/eurheartj\/ehv063","article-title":"Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives","volume":"36","author":"Semsarian","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fcvm.2017.00072","article-title":"Molecular autopsy for sudden death in the young: is data aggregation the key?","volume":"4","author":"Rueda","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"2026080912175992400_euac030-B88","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1001\/jama.2016.11445","article-title":"Molecular autopsy for sudden unexpected death","volume":"316","author":"Torkamani","year":"2016","journal-title":"JAMA"},{"key":"2026080912175992400_euac030-B89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"2026080912175992400_euac030-B90","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.112.001216","article-title":"Calmodulin mutations associated with recurrent cardiac arrest in infants","volume":"127","author":"Crotti","year":"2013","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B91","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/eurheartj\/ehz311","article-title":"Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry","volume":"40","author":"Crotti","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B92","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.115.015397","article-title":"Homozygous\/compound heterozygous triadin mutations associated with autosomal-recessive long-QT syndrome and pediatric sudden cardiac arrest: elucidation of the Triadin knockout syndrome","volume":"131","author":"Altmann","year":"2015","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B93","doi-asserted-by":"crossref","first-page":"e002419","DOI":"10.1161\/CIRCGEN.118.002419","article-title":"International Triadin knockout syndrome registry","volume":"12","author":"Clemens","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B94","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/eurheartj\/ehv695","article-title":"The genetics underlying acquired long QT syndrome: impact for genetic screening","volume":"37","author":"Itoh","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCRESAHA.110.224600","article-title":"Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels","volume":"109","author":"Shimizu","year":"2011","journal-title":"Circ Res"},{"key":"2026080912175992400_euac030-B96","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/cvr\/cvaa068","article-title":"Heritable arrhythmias associated with abnormal function of cardiac potassium channels","volume":"116","author":"Crotti","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026080912175992400_euac030-B97","first-page":"263","article-title":"[Ventricular tachycardia with 2 variable opposing foci]","volume":"59","author":"Dessertenne","year":"1966","journal-title":"Arch Mal Coeur Vaiss"},{"key":"2026080912175992400_euac030-B98","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(99)02107-8","article-title":"Long QT syndromes and torsade de pointes","volume":"354","author":"Viskin","year":"1999","journal-title":"Lancet"},{"key":"2026080912175992400_euac030-B99","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.CIR.0000048142.85076.A2","article-title":"Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome","volume":"107","author":"Takenaka","year":"2003","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B100","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/CIRCULATIONAHA.111.028258","article-title":"Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands","volume":"124","author":"Sy","year":"2011","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B101","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/CIRCULATIONAHA.111.062182","article-title":"QTc behavior during exercise and genetic testing for the long-QT syndrome","volume":"124","author":"Schwartz","year":"2011","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B102","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.71.1.17","article-title":"The long QT syndrome: a prospective international study","volume":"71","author":"Moss","year":"1985","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B104","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0002-8703(85)90626-X","article-title":"Idiopathic long QT syndrome: progress and questions","volume":"109","author":"Schwartz","year":"1985","journal-title":"Am Heart J"},{"key":"2026080912175992400_euac030-B105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCULATIONAHA.105.592899","article-title":"The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome","volume":"113","author":"Schwartz","year":"2006","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B106","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.119.043114","article-title":"An international multicenter evaluation of type 5 long QT syndrome: a low penetrant primary arrhythmic condition","volume":"141","author":"Roberts","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B107","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2020.02.033","article-title":"Natural history and risk stratification in Andersen-Tawil syndrome type 1","volume":"75","author":"Mazzanti","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B108","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCEP.108.788349","article-title":"Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel","volume":"1","author":"Wang","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B109","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ccep.2014.07.009","article-title":"The role of the cardiac sodium channel in perinatal early infant mortality","volume":"6","author":"Crotti","year":"2014","journal-title":"Card Electrophysiol Clin"},{"key":"2026080912175992400_euac030-B110","first-page":"2219","article-title":"The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome","volume":"118","author":"Makita","year":"2008","journal-title":"J Clin Invest"},{"key":"2026080912175992400_euac030-B111","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cvr\/cvx006","article-title":"Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes","volume":"113","author":"Rocchetti","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2026080912175992400_euac030-B112","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-020-0188-7","article-title":"Inherited cardiac arrhythmias","volume":"6","author":"Schwartz","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026080912175992400_euac030-B113","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1161\/CIRCULATIONAHA.120.048916","article-title":"Exercise training-induced repolarization abnormalities masquerading as congenital long QT syndrome","volume":"142","author":"Dagradi","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B114","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.CIR.99.4.529","article-title":"Low penetrance in the long-QT syndrome: clinical impact","volume":"99","author":"Priori","year":"1999","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0735-1097(02)02850-4","article-title":"Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome","volume":"41","author":"Shimizu","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B116","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacc.2010.07.038","article-title":"Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals","volume":"57","author":"Goldenberg","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B117","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2018.01.078","article-title":"Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome","volume":"71","author":"Mazzanti","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B118","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jacc.2009.08.028","article-title":"Genotype-phenotype aspects of type 2 long QT syndrome","volume":"54","author":"Shimizu","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B119","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1093\/eurheartj\/ehab582","article-title":"Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region","volume":"42","author":"Schwartz","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B120","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1161\/CIRCULATIONAHA.106.665406","article-title":"Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene","volume":"115","author":"Moss","year":"2007","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B121","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1161\/CIRCULATIONAHA.107.726950","article-title":"The common long-QT syndrome mutation KCNQ1\/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification","volume":"116","author":"Crotti","year":"2007","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B122","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an International Multicenter Study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B123","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cvr\/cvaa019","article-title":"MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes","volume":"117","author":"Lee","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2026080912175992400_euac030-B124","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.108.772533","article-title":"High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment \u201cfailures\u201d","volume":"119","author":"Vincent","year":"2009","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B125","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/CIRCULATIONAHA.111.048041","article-title":"Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type 1 long-QT syndrome","volume":"125","author":"Barsheshet","year":"2012","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B126","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000125523.14403.1E","article-title":"Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome","volume":"109","author":"Schwartz","year":"2004","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B127","article-title":"Left cardiac sympathetic denervation for long QT syndrome: 50 years\u2019 experience provides guidance for management","author":"Dusi","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2026080912175992400_euac030-B128","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jacc.2003.07.006","article-title":"A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations","volume":"42","author":"Etheridge","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0735-1097(98)00578-6","article-title":"Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1)","volume":"33","author":"Wilde","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B131","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.hrthm.2004.01.006","article-title":"Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome","volume":"1","author":"Khositseth","year":"2004","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B132","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy","volume":"92","author":"Schwartz","year":"1995","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B133","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B134","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1253\/circj.CJ-15-0984","article-title":"Pronounced shortening of QT interval with mexiletine infusion test in patients with type 3 congenital long QT syndrome","volume":"80","author":"Funasako","year":"2016","journal-title":"Circ J"},{"key":"2026080912175992400_euac030-B135","doi-asserted-by":"crossref","first-page":"e007280","DOI":"10.1161\/CIRCEP.118.007280","article-title":"Mexiletine shortens the QT interval in patients with potassium channel-mediated type 2 long QT syndrome","volume":"12","author":"Bos","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B136","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/eurheartj\/ehx394","article-title":"Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model","volume":"39","author":"Mehta","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B137","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehz023","article-title":"From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2","volume":"40","author":"Schwartz","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B138","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and Torsades de Pointes","volume":"67","author":"Schwartz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B139","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCGENETICS.111.960930","article-title":"A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes","volume":"5","author":"K\u00e4\u00e4b","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B140","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/CIRCULATIONAHA.116.023980","article-title":"Common genetic variant risk score is associated with drug-induced QT prolongation and Torsade de Pointes risk: a pilot study","volume":"135","author":"Strauss","year":"2017","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/17431380410032517","article-title":"A missense mutation in CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel","volume":"36","author":"Lahat","year":"2004","journal-title":"Ann Med"},{"key":"2026080912175992400_euac030-B142","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/hmg\/dds104","article-title":"Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human","volume":"21","author":"Roux-Buisson","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2026080912175992400_euac030-B143","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.15252\/emmm.201505719","article-title":"TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT","volume":"8","author":"Devalla","year":"2016","journal-title":"EMBO Mol Med"},{"key":"2026080912175992400_euac030-B144","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/europace\/euaa376","article-title":"Life-threatening arrhythmias with autosomal recessive TECRL variants","volume":"23","author":"Webster","year":"2021","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B145","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","article-title":"The RYR2-encoded ryanodine receptor\/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis","volume":"54","author":"Medeiros-Domingo","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B146","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2012.02.052","article-title":"Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy","volume":"60","author":"Laurent","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B147","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCGENETICS.114.000703","article-title":"Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias","volume":"7","author":"Swan","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B148","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacep.2018.09.010","article-title":"Plakophilin-2 truncation variants in patients clinically diagnosed with catecholaminergic polymorphic ventricular tachycardia and decedents with exercise-associated autopsy negative sudden unexplained death in\u00a0the young","volume":"5","author":"Tester","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2026080912175992400_euac030-B149","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives","volume":"5","author":"van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B151","doi-asserted-by":"crossref","first-page":"e002510","DOI":"10.1161\/CIRCGEN.119.002510","article-title":"Assessment and validation of a phenotype-enhanced variant classification framework to promote or demote RYR2 missense variants of uncertain significance","volume":"12","author":"Giudicessi","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B152","first-page":"28","article-title":"Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases","volume":"40","author":"Coumel","year":"1978","journal-title":"Br Heart J"},{"key":"2026080912175992400_euac030-B153","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B154","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4065\/79.11.1380","article-title":"Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner\/coroner's cases","volume":"79","author":"Tester","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"2026080912175992400_euac030-B155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1540-8167.2011.02185.x","article-title":"Sentinel symptoms in patients with unexplained cardiac arrest: from the cardiac arrest survivors with preserved ejection fraction registry (CASPER)","volume":"23","author":"Krahn","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080912175992400_euac030-B156","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.jacc.2020.04.004","article-title":"A population-based registry of patients with inherited cardiac conditions and resuscitated cardiac arrest","volume":"75","author":"Rucinski","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B157","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijcard.2017.10.016","article-title":"The genetics underlying idiopathic ventricular fibrillation: a special role for catecholaminergic polymorphic ventricular tachycardia?","volume":"250","author":"Leinonen","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026080912175992400_euac030-B158","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.hrthm.2007.02.026","article-title":"A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors","volume":"4","author":"Tester","year":"2007","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B159","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.CIR.103.4.485","article-title":"Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia","volume":"103","author":"Laitinen","year":"2001","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B161","doi-asserted-by":"crossref","first-page":"eaba7287","DOI":"10.1126\/scitranslmed.aba7287","article-title":"Cardiac ryanodine receptor calcium release deficiency syndrome","volume":"13","author":"Sun","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026080912175992400_euac030-B162","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamacardio.2021.4458","article-title":"Clinical and functional characterization of ryanodine receptor 2 variants implicated in calcium-release deficiency syndrome","volume":"7","author":"Roston","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026080912175992400_euac030-B163","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.hrthm.2006.03.025","article-title":"Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing","volume":"3","author":"Tester","year":"2006","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B164","doi-asserted-by":"crossref","first-page":"e001424","DOI":"10.1161\/CIRCGEN.116.001424","article-title":"Yield of the RYR2 genetic test in suspected catecholaminergic polymorphic ventricular tachycardia and implications for test interpretation","volume":"11","author":"Kapplinger","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B165","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.hrthm.2016.05.004","article-title":"A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Gray","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B166","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.120.045723","article-title":"An international multicenter evaluation of inheritance patterns, arrhythmic risks, and underlying mechanisms of CASQ2-catecholaminergic polymorphic ventricular tachycardia","volume":"142","author":"Ng","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B167","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/europace\/eur277","article-title":"Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments","volume":"14","author":"van der Werf","year":"2012","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B168","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026080912175992400_euac030-B169","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B170","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/eurheartj\/ehz309","article-title":"Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest","volume":"40","author":"van der Werf","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B171","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphys.2019.00103","article-title":"Meta-analysis of risk stratification of SCN5A with Brugada syndrome: is SCN5A always a marker of low risk?","volume":"10","author":"Yang","year":"2019","journal-title":"Front Physiol"},{"key":"2026080912175992400_euac030-B172","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41436-020-00946-5","article-title":"Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls","volume":"23","author":"Walsh","year":"2021","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B173","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/europace\/eus042","article-title":"About Brugada syndrome and its prevalence","volume":"14","author":"Postema","year":"2012","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B174","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hrthm.2018.01.014","article-title":"Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS)","volume":"15","author":"Milman","year":"2018","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3904\/kjim.2020.481","article-title":"Inherited arrhythmia syndrome predisposing to sudden cardiac death","volume":"36","author":"Kim","year":"2021","journal-title":"Korean J Intern Med"},{"key":"2026080912175992400_euac030-B176","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jacc.2018.01.031","article-title":"The diagnostic yield of Brugada syndrome after sudden death with normal autopsy","volume":"71","author":"Papadakis","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B177","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jacep.2017.04.005","article-title":"Yield and pitfalls of ajmaline testing in the evaluation of unexplained cardiac arrest and sudden unexplained death: single-center experience with 482 families","volume":"3","author":"Tadros","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2026080912175992400_euac030-B178","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1540-8167.2000.tb00334.x","article-title":"Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms","volume":"11","author":"Shimizu","year":"2000","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080912175992400_euac030-B179","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.hrthm.2015.04.017","article-title":"Everybody has Brugada syndrome until proven otherwise?","volume":"12","author":"Viskin","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B180","first-page":"665","article-title":"J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"19","author":"Antzelevitch","year":"2017","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B181","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1542-474X.2012.00525.x","article-title":"Brugada phenocopy: new terminology and proposed classification","volume":"17","author":"Baranchuk","year":"2012","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026080912175992400_euac030-B182","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B183","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.hrthm.2017.06.033","article-title":"Risk of arrhythmic events in drug-induced Brugada syndrome","volume":"14","author":"Lahrouchi","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B184","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.hrthm.2009.07.002","article-title":"Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)","volume":"6","author":"Postema","year":"2009","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B185","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B186","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCULATIONAHA.120.045720","article-title":"In children and adolescents from Brugada syndrome-families, only SCN5A mutation carriers develop a type-1 ECG pattern induced by fever","volume":"142","author":"Peltenburg","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B187","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.RES.85.12.1206","article-title":"A single Na(+) channel mutation causing both long-QT and Brugada syndromes","volume":"85","author":"Bezzina","year":"1999","journal-title":"Circ Res"},{"key":"2026080912175992400_euac030-B188","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1111\/jce.14732","article-title":"Low rate of life-threatening events and limitations in predicting invasive and noninvasive markers of symptoms in a cohort of type 1 Brugada syndrome patients: data and insights from the GenBra registry","volume":"31","author":"Sacilotto","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080912175992400_euac030-B189","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.117.027983","article-title":"Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with brugada syndrome: a Japanese Multicenter Registry","volume":"135","author":"Yamagata","year":"2017","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B190","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/eurheartj\/ehaa942","article-title":"Brugada syndrome genetics is associated with phenotype severity","volume":"42","author":"Ciconte","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B191","first-page":"e333","article-title":"2018 ACC\/AHA\/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B192","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacc.2008.12.013","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology","volume":"53","author":"Surawicz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B193","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/europace\/euz109","article-title":"Molecular and genetic insights into progressive cardiac conduction disease","volume":"21","author":"Asatryan","year":"2019","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B194","doi-asserted-by":"crossref","first-page":"E1609","DOI":"10.1002\/humu.21302","article-title":"A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease","volume":"31","author":"Neu","year":"2010","journal-title":"Hum Mutat"},{"key":"2026080912175992400_euac030-B195","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1172\/JCI200318062","article-title":"Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A)","volume":"112","author":"Benson","year":"2003","journal-title":"J Clin Invest"},{"key":"2026080912175992400_euac030-B196","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1161\/hc5001.100834","article-title":"Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family","volume":"104","author":"Kyndt","year":"2001","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B197","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B198","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B199","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11886-019-1236-3","article-title":"Risk stratification for sudden cardiac death in non-ischaemic dilated cardiomyopathy","volume":"21","author":"Akhtar","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"2026080912175992400_euac030-B200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B201","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers a European cohort study","volume":"59","author":"Van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B202","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1253\/circj.CJ-18-0339","article-title":"Clinical manifestations and long-term mortality in lamin A\/C mutation carriers from a Japanese Multicenter Registry","volume":"82","author":"Nakajima","year":"2018","journal-title":"Circ J"},{"key":"2026080912175992400_euac030-B203","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/pace.13386","article-title":"A homozygous SCN5A mutation associated with atrial standstill and sudden death","volume":"41","author":"Tan","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080912175992400_euac030-B204","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.hrthm.2005.06.032","article-title":"Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms","volume":"2","author":"Makita","year":"2005","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B205","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1172\/JCI38292","article-title":"Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I","volume":"119","author":"Kruse","year":"2009","journal-title":"J Clin Invest"},{"key":"2026080912175992400_euac030-B206","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2016.01.052","article-title":"Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type I","volume":"207","author":"Daumy","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080912175992400_euac030-B207","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B208","first-page":"385","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member","volume":"69","author":"Brook","year":"1992","journal-title":"Cell"},{"key":"2026080912175992400_euac030-B209","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/B978-0-444-59565-2.00007-1","article-title":"Emery-Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies","volume":"113","author":"Bonne","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"2026080912175992400_euac030-B210","doi-asserted-by":"crossref","first-page":"e008712","DOI":"10.1161\/CIRCEP.120.008712","article-title":"Cardiac emerinopathy: a nonsyndromic nuclear envelopathy with increased risk of thromboembolic stroke due to progressive atrial standstill and left ventricular noncompaction","volume":"13","author":"Ishikawa","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B211","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/nan.12587","article-title":"Review: Danon disease: review of natural history and recent advances","volume":"46","author":"Cenacchi","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2026080912175992400_euac030-B212","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2018.08.2182","article-title":"Cardiac phenotypes in hereditary muscle disorders: JACC state-of-the-art review","volume":"72","author":"Arbustini","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B213","doi-asserted-by":"crossref","first-page":"102723","DOI":"10.1016\/j.ebiom.2020.102723","article-title":"Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease","volume":"54","author":"Hu","year":"2020","journal-title":"EBioMedicine"},{"key":"2026080912175992400_euac030-B214","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1093\/hmg\/ddu297","article-title":"TNNI3K mutation in familial syndrome of conduction system disease, atrial tachyarrhythmia and dilated cardiomyopathy","volume":"23","author":"Theis","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2026080912175992400_euac030-B215","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jacc.2017.05.039","article-title":"Progressive atrial conduction defects associated with bone malformation caused by a connexin-45 mutation","volume":"70","author":"Seki","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B216","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/heartjnl-2015-308193","article-title":"Mitochondrial disease and the heart","volume":"103","author":"Limongelli","year":"2017","journal-title":"Heart"},{"key":"2026080912175992400_euac030-B217","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.RES.0000162101.76263.8c","article-title":"A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene","volume":"96","author":"Priori","year":"2005","journal-title":"Circ Res"},{"key":"2026080912175992400_euac030-B218","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/eurheartj\/ehr076","article-title":"Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6)","volume":"32","author":"Templin","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B219","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2010.09.048","article-title":"The short QT syndrome: proposed diagnostic criteria","volume":"57","author":"Gollob","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B220","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/europace\/euu351","article-title":"Usefulness of exercise test in the diagnosis of short QT syndrome","volume":"17","author":"Giustetto","year":"2015","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B221","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG","volume":"109","author":"Brugada","year":"2004","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B222","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.CIR.0000130409.72142.FE","article-title":"Mutation in the KCNQ1 gene leading to the short QT-interval syndrome","volume":"109","author":"Bellocq","year":"2004","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B223","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41467-017-01630-0","article-title":"Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger AE3 causes short QT syndrome","volume":"8","author":"Thorsen","year":"2017","journal-title":"Nat Commun"},{"key":"2026080912175992400_euac030-B224","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","article-title":"Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death","volume":"115","author":"Antzelevitch","year":"2007","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14728222.2018.1470621","article-title":"Emerging therapeutic targets in the short QT syndrome","volume":"22","author":"Hancox","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"2026080912175992400_euac030-B226","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/5030","article-title":"Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter","volume":"21","author":"Nezu","year":"1999","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B227","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.hrthm.2015.07.027","article-title":"Carnitine deficiency induces a short QT syndrome","volume":"13","author":"Roussel","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B228","first-page":"1256.e1\u20132","article-title":"Molecular autopsy implicates primary carnitine deficiency in sudden unexplained death and reversible short QT syndrome","volume":"35","author":"G\u00e9linas","year":"2019","journal-title":"Can J Cardiol"},{"key":"2026080912175992400_euac030-B229","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome","volume":"58","author":"Giustetto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B230","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jacep.2016.11.013","article-title":"The phenotypic spectrum of a mutation\u00a0hotspot responsible for the\u00a0short QT syndrome","volume":"3","author":"Hu","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2026080912175992400_euac030-B231","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jacc.2017.10.025","article-title":"Hydroquinidine prevents life-threatening arrhythmic events in patients with short\u00a0QT\u00a0syndrome","volume":"70","author":"Mazzanti","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B232","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fgene.2019.01312","article-title":"Differences in short QT syndrome subtypes: a systematic literature review and pooled analysis","volume":"10","author":"Raschwitz","year":"2019","journal-title":"Front Genet"},{"key":"2026080912175992400_euac030-B233","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijcard.2015.04.090","article-title":"Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome","volume":"190","author":"Harrell","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080912175992400_euac030-B234","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0735-1097(02)02167-8","article-title":"Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome","volume":"40","author":"Morita","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B235","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"},{"key":"2026080912175992400_euac030-B236","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.0000144458.58660.BB","article-title":"SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia","volume":"110","author":"McNair","year":"2004","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B237","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2009.01.052","article-title":"Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing","volume":"380","author":"Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2026080912175992400_euac030-B238","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1077771","article-title":"KCNQ1 gain-of-function mutation in familial atrial fibrillation","volume":"299","author":"Chen","year":"2003","journal-title":"Science"},{"key":"2026080912175992400_euac030-B239","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1038\/ncomms11303","article-title":"A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation","volume":"7","author":"Orr","year":"2016","journal-title":"Nat Commun"},{"key":"2026080912175992400_euac030-B240","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B241","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1001\/jama.2018.18179","article-title":"Association between titin loss-of-function variants and early-onset atrial fibrillation","volume":"320","author":"Choi","year":"2018","journal-title":"JAMA"},{"key":"2026080912175992400_euac030-B242","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jamacardio.2021.3370","article-title":"Early-onset atrial fibrillation and the prevalence of rare variants in cardiomyopathy and arrhythmia genes","volume":"6","author":"Yoneda","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026080912175992400_euac030-B243","doi-asserted-by":"crossref","first-page":"e002713","DOI":"10.1161\/CIRCGEN.119.002713","article-title":"Broad genetic testing in a clinical setting uncovers a high prevalence of titin loss-of-function variants in very early onset atrial fibrillation","volume":"12","author":"Goodyer","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B244","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ncpcardio0509","article-title":"Mechanisms of disease: genetic mechanisms of atrial fibrillation","volume":"3","author":"Roberts","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2026080912175992400_euac030-B245","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0735-1097(03)00465-0","article-title":"Familial atrial fibrillation is a genetically heterogeneous disorder","volume":"41","author":"Darbar","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B246","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/jmg.40.8.560","article-title":"Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations","volume":"40","author":"S\u00e9billon","year":"2003","journal-title":"J Med Genet"},{"key":"2026080912175992400_euac030-B247","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nature01335","article-title":"Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death","volume":"421","author":"Mohler","year":"2003","journal-title":"Nature"},{"key":"2026080912175992400_euac030-B248","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cardiores.2005.06.023","article-title":"De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero","volume":"68","author":"Hong","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2026080912175992400_euac030-B249","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.107.711606","article-title":"Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features","volume":"116","author":"Bhuiyan","year":"2007","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B250","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"Sy","year":"2011","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B251","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/hrt.82.3.e2","article-title":"Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man","volume":"82","author":"Gillmore","year":"1999","journal-title":"Heart"},{"key":"2026080912175992400_euac030-B252","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.ejhg.5201702","article-title":"A novel CSX\/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype?","volume":"14","author":"Gutierrez-Roelens","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"2026080912175992400_euac030-B253","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1161\/hc5001.102111","article-title":"Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy","volume":"104","author":"Gollob","year":"2001","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B254","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","article-title":"2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"57","author":"Fuster","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B255","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/hmg\/ddl143","article-title":"Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation","volume":"15","author":"Olson","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2026080912175992400_euac030-B256","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1073\/pnas.1218154110","article-title":"KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia","volume":"110","author":"Deo","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026080912175992400_euac030-B257","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1540-8167.2005.40621.x","article-title":"Short QT syndrome and atrial fibrillation caused by mutation in KCNH2","volume":"16","author":"Hong","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080912175992400_euac030-B258","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.hrthm.2020.12.033","article-title":"Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease","volume":"18","author":"Li","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B259","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa0706300","article-title":"Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation","volume":"359","author":"Hodgson-Zingman","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B260","first-page":"e382","article-title":"2018 ACC\/AHA\/HRS Guideline on the evaluation and management of patients with Bradycardia and cardiac conduction delay: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B261","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/heartjnl-2016-310986","article-title":"Heritability of resting heart rate and association with mortality in middle-aged and elderly twins","volume":"104","author":"Jensen","year":"2018","journal-title":"Heart"},{"key":"2026080912175992400_euac030-B262","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng.511","article-title":"Several common variants modulate heart rate, PR interval and QRS duration","volume":"42","author":"Holm","year":"2010","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B263","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng.781","article-title":"A rare variant in MYH6 is associated with high risk of sick sinus syndrome","volume":"43","author":"Holm","year":"2011","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B264","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s41467-018-04148-1","article-title":"Thirty loci identified for heart rate response to exercise and recovery implicate autonomic nervous system","volume":"9","author":"Ramirez","year":"2018","journal-title":"Nat Commun"},{"key":"2026080912175992400_euac030-B265","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2018.10.043","article-title":"2018 ACC\/AHA\/HRS Guideline on the evaluation and management of patients with Bradycardia and cardiac conduction delay: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B266","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.RES.0000069689.09869.A8","article-title":"Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families","volume":"92","author":"Veldkamp","year":"2003","journal-title":"Circ Res"},{"key":"2026080912175992400_euac030-B267","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCEP.115.003098","article-title":"Loss-of-function SCN5A mutations associated with sinus node dysfunction, atrial arrhythmias, and poor pacemaker capture","volume":"8","author":"Chiang","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B268","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1172\/JCI200316387","article-title":"Pacemaker channel dysfunction in a patient with sinus node disease","volume":"111","author":"Schulze-Bahr","year":"2003","journal-title":"J Clin Invest"},{"key":"2026080912175992400_euac030-B269","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jacc.2014.05.045","article-title":"HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy","volume":"64","author":"Milano","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B270","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1161\/CIRCRESAHA.116.310112","article-title":"A mutation in the G-protein gene GNB2 causes familial sinus node and atrioventricular conduction dysfunction","volume":"120","author":"Stallmeyer","year":"2017","journal-title":"Circ Res"},{"key":"2026080912175992400_euac030-B271","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S1047951115001432","article-title":"Sinus bradycardia, junctional rhythm, and low-rate atrial fibrillation in Short QT syndrome during 20 years of follow-up: three faces of the same genetic problem","volume":"26","author":"Righi","year":"2016","journal-title":"Cardiol Young"},{"key":"2026080912175992400_euac030-B272","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3389\/fphys.2018.01402","article-title":"Human atrial arrhythmogenesis and sinus bradycardia in KCNQ1-linked short QT syndrome: insights from computational modelling","volume":"9","author":"Whittaker","year":"2018","journal-title":"Front Physiol"},{"key":"2026080912175992400_euac030-B273","doi-asserted-by":"crossref","first-page":"e002238","DOI":"10.1161\/CIRCGEN.118.002238","article-title":"Familial sinus node disease caused by a gain of GIRK (G-protein activated inwardly rectifying K(+) channel) channel function","volume":"12","author":"Ku\u00df","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B274","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1161\/CIRCULATIONAHA.118.036761","article-title":"Mutant KCNJ3 and KCNJ5 potassium channels as novel molecular targets in bradyarrhythmias and atrial fibrillation","volume":"139","author":"Yamada","year":"2019","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2020.04.017","article-title":"Distinct mechanisms mediate pacemaker dysfunction associated with catecholaminergic polymorphic ventricular tachycardia mutations: insights from computational modeling","volume":"143","author":"Arbel-Ganon","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"2026080912175992400_euac030-B276","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nn.2694","article-title":"Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness","volume":"14","author":"Baig","year":"2011","journal-title":"Nat Neurosci"},{"key":"2026080912175992400_euac030-B277","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s10038-018-0542-8","article-title":"Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance","volume":"64","author":"Liaqat","year":"2019","journal-title":"J Hum Genet"},{"key":"2026080912175992400_euac030-B278","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ajhg.2016.08.011","article-title":"GNB5 mutations cause an autosomal-recessive multisystem syndrome with sinus bradycardia and cognitive disability","volume":"99","author":"Lodder","year":"2016","journal-title":"Am J Hum Genet"},{"key":"2026080912175992400_euac030-B279","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ng.3113","article-title":"Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm","volume":"46","author":"Chetaille","year":"2014","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B280","first-page":"319","article-title":"A novel mutation of the EMD gene in a family with cardiac conduction abnormalities and a high incidence of sudden cardiac death","volume":"12","author":"Kong","year":"2019","journal-title":"Pharmgenomics Pers Med"},{"key":"2026080912175992400_euac030-B281","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0002-9149(61)90204-1","article-title":"The normal RS-T segment elevation variant","volume":"8","author":"Wasserburger","year":"1961","journal-title":"Am J Cardiol"},{"key":"2026080912175992400_euac030-B282","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa0907589","article-title":"Long-term outcome associated with early repolarization on electrocardiography","volume":"361","author":"Tikkanen","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B283","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2008.07.010","article-title":"J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance","volume":"52","author":"Rosso","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B284","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa071968","article-title":"Sudden cardiac arrest associated with early repolarization","volume":"358","author":"Ha\u00efssaguerre","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B285","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jacc.2013.05.030","article-title":"Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization","volume":"62","author":"Aizawa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B286","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMc0708182","article-title":"Augmentation of J waves and electrical storms in patients with early repolarization","volume":"358","author":"Nam","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B287","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2013.12.012","article-title":"Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome","volume":"68","author":"Koncz","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2026080912175992400_euac030-B288","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.hrthm.2009.12.005","article-title":"Early repolarization associated with sudden death: insights from noninvasive electrocardiographic imaging","volume":"7","author":"Ghosh","year":"2010","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B289","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCULATIONAHA.118.039022","article-title":"Mapping and ablation of ventricular fibrillation associated with early repolarization syndrome","volume":"140","author":"Nademanee","year":"2019","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B290","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.hrthm.2018.10.040","article-title":"Depolarization versus repolarization abnormality underlying inferolateral J-wave syndromes: new concepts in sudden cardiac death with apparently normal hearts","volume":"16","author":"Ha\u00efssaguerre","year":"2019","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B291","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jacep.2020.06.027","article-title":"Structurally abnormal myocardium underlies ventricular fibrillation storms in a patient diagnosed with the early\u00a0repolarization pattern","volume":"6","author":"Boukens","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2026080912175992400_euac030-B292","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCGENETICS.110.958298","article-title":"Heritability of early repolarization: a population-based study","volume":"4","author":"Reinhard","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B293","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2018.09.119","article-title":"The narrow-sense and common single nucleotide polymorphism heritability of early repolarization","volume":"279","author":"Bastiaenen","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026080912175992400_euac030-B294","first-page":"1874","article-title":"Medium-term outcomes of idiopathic ventricular fibrillation survivors and family screening: a multicentre experience","volume":"19","author":"Honarbakhsh","year":"2017","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B295","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jacc.2011.03.028","article-title":"Prevalence of J-point elevation in sudden arrhythmic death syndrome families","volume":"58","author":"Nunn","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B296","doi-asserted-by":"crossref","first-page":"e003960","DOI":"10.1161\/CIRCEP.116.003960","article-title":"The prevalence and significance of the early repolarization pattern in sudden arrhythmic death syndrome families","volume":"9","author":"Mellor","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B297","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCEP.111.963983","article-title":"Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization","volume":"4","author":"Watanabe","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B298","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/europace\/euz337","article-title":"Prevalence and electrophysiological phenotype of rare SCN5A genetic variants identified in unexplained sudden cardiac arrest survivors","volume":"22","author":"Giudicessi","year":"2020","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B299","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jacc.2021.08.024","article-title":"Distinct features of probands with early repolarization and brugada syndromes carrying SCN5A pathogenic variants","volume":"78","author":"Zhang","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B300","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.hrcr.2017.08.003","article-title":"Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing","volume":"3","author":"Chauveau","year":"2017","journal-title":"HeartRhythm Case Rep"},{"key":"2026080912175992400_euac030-B301","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.hrthm.2019.05.033","article-title":"A de novo gain-of-function KCND3 mutation in early repolarization syndrome","volume":"16","author":"Takayama","year":"2019","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B302","doi-asserted-by":"crossref","first-page":"e131156","DOI":"10.1172\/jci.insight.131156","article-title":"KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern","volume":"4","author":"Teumer","year":"2019","journal-title":"JCI Insight"},{"key":"2026080912175992400_euac030-B303","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.hrthm.2011.10.035","article-title":"Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8","volume":"9","author":"Barajas-Mart\u00ednez","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B304","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.hrthm.2010.06.016","article-title":"Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes","volume":"7","author":"Medeiros-Domingo","year":"2010","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM198707093170201","article-title":"Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome)","volume":"317","author":"Vidaillet","year":"1987","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B306","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0735-1097(85)80095-4","article-title":"Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up","volume":"5","author":"Deal","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B307","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1172\/JCI118154","article-title":"Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3","volume":"96","author":"MacRae","year":"1995","journal-title":"J Clin Invest"},{"key":"2026080912175992400_euac030-B308","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM200106143442403","article-title":"Identification of a gene responsible for familial Wolff-Parkinson-White syndrome","volume":"344","author":"Gollob","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B309","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jacc.2020.05.029","article-title":"Clinical features and natural history of PRKAG2 variant cardiac glycogenosis","volume":"76","author":"Lopez-Sainz","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B310","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yjmcc.2008.05.003","article-title":"Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C","volume":"45","author":"Landstrom","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"2026080912175992400_euac030-B311","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/hmg\/ddn160","article-title":"Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy","volume":"17","author":"Geier","year":"2008","journal-title":"Hum Mol Genet"},{"key":"2026080912175992400_euac030-B312","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.yjmcc.2007.04.006","article-title":"Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans","volume":"42","author":"Landstrom","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"2026080912175992400_euac030-B313","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/ajmg.a.61176","article-title":"Phenotypic spectrum of ALPK3-related cardiomyopathy","volume":"179","author":"Al Senaidi","year":"2019","journal-title":"Am J Med Genet A"},{"key":"2026080912175992400_euac030-B314","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.jacc.2018.10.001","article-title":"Formin homology 2 domain containing 3 (FHOD3) is a genetic basis for hypertrophic cardiomyopathy","volume":"72","author":"Ochoa","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B315","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B316","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/gim.2013.44","article-title":"Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy","volume":"15","author":"Ingles","year":"2013","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B317","doi-asserted-by":"crossref","first-page":"e001896","DOI":"10.1161\/CIRCGEN.117.001896","article-title":"Outcomes of contemporary family screening in hypertrophic cardiomyopathy","volume":"11","author":"van Velzen","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B318","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.118.038846","article-title":"Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives","volume":"140","author":"Norrish","year":"2019","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B319","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ehjci\/jeaa176","article-title":"Glycogen storage cardiomyopathy (PRKAG2): diagnostic findings of standard and advanced echocardiography techniques","volume":"22","author":"Pena","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080912175992400_euac030-B320","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"key":"2026080912175992400_euac030-B321","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1136\/heartjnl-2011-300364","article-title":"Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey","volume":"97","author":"Elliott","year":"2011","journal-title":"Heart"},{"key":"2026080912175992400_euac030-B322","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B323","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41467-017-01342-5","article-title":"Mammalian \u03b32 AMPK regulates intrinsic heart rate","volume":"8","author":"Yavari","year":"2017","journal-title":"Nat Commun"},{"key":"2026080912175992400_euac030-B324","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2010.09.081","article-title":"Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: the role of PRKAG2 mutation","volume":"8","author":"Sternick","year":"2011","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B325","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/gim.2013.138","article-title":"Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment","volume":"16","author":"Das","year":"2014","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B326","doi-asserted-by":"crossref","first-page":"e000054","DOI":"10.1161\/HCG.0000000000000054","article-title":"Establishment of specialized clinical cardiovascular genetics programs: recognizing the need and meeting standards: a scientific statement from the American Heart Association","volume":"12","author":"Ahmad","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B327","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/CIRCULATIONAHA.114.013478","article-title":"Risk of cardiomyopathy in younger persons with a family history of death from cardiomyopathy: a nationwide family study in a cohort of 3.9 million persons","volume":"132","author":"Ranthe","year":"2015","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B328","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","article-title":"Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy","volume":"72","author":"Bagnall","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B329","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B330","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41436-018-0375-z","article-title":"Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield","volume":"21","author":"Thomson","year":"2019","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B331","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1038\/ncomms6326","article-title":"Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy","volume":"5","author":"Vald\u00e9s-Mas","year":"2014","journal-title":"Nat Commun"},{"key":"2026080912175992400_euac030-B332","doi-asserted-by":"crossref","first-page":"e001620","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B333","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2018.07.091","article-title":"Cardiac outcome in classic infantile Pompe disease after 13\u202fyears of treatment with recombinant human acid alpha-glucosidase","volume":"269","author":"van Capelle","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026080912175992400_euac030-B334","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ahj.2010.08.001","article-title":"PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing","volume":"161","author":"Landstrom","year":"2011","journal-title":"Am Heart J"},{"key":"2026080912175992400_euac030-B335","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/gim.2016.32","article-title":"Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation","volume":"18","author":"Kouz","year":"2016","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B336","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cge.13157","article-title":"Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy","volume":"93","author":"Mathew","year":"2018","journal-title":"Clin Genet"},{"key":"2026080912175992400_euac030-B337","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1136\/jmg.2005.033886","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling","volume":"42","author":"Ingles","year":"2005","journal-title":"J Med Genet"},{"key":"2026080912175992400_euac030-B338","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B339","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/eurheartj\/ehr092","article-title":"Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy","volume":"32","author":"Christiaans","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B340","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy","volume":"36","author":"Haas","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B341","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","article-title":"Genetic etiology for alcohol-induced cardiac toxicity","volume":"71","author":"Ware","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B342","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B343","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ejhf.1384","article-title":"External validation of risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers","volume":"21","author":"Thuillot","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026080912175992400_euac030-B344","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.hlc.2018.09.010","article-title":"Arrhythmic genotypes in familial dilated cardiomyopathy: implications for genetic testing and clinical management","volume":"28","author":"Peters","year":"2019","journal-title":"Heart Lung Circ"},{"key":"2026080912175992400_euac030-B345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","article-title":"Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals","volume":"106","author":"Kayvanpour","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2026080912175992400_euac030-B346","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B347","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cge.13594","article-title":"FLNC pathogenic variants in patients with cardiomyopathies: prevalence and genotype-phenotype correlations","volume":"96","author":"Ader","year":"2019","journal-title":"Clin Genet"},{"key":"2026080912175992400_euac030-B348","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nmd.2011.10.019","article-title":"High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study","volume":"22","author":"Wahbi","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"2026080912175992400_euac030-B349","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/ehf2.12925","article-title":"ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients","volume":"7","author":"Heli\u00f6","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026080912175992400_euac030-B350","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/ejhg.2009.26","article-title":"Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics","volume":"17","author":"European Society of Human Genetics","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"2026080912175992400_euac030-B351","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B352","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.CIR.81.2.506","article-title":"Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation","volume":"81","author":"Keren","year":"1990","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B353","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0735-1097(97)00434-8","article-title":"Frequency and phenotypes of familial dilated cardiomyopathy","volume":"31","author":"Grunig","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B354","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-143-2-200507190-00009","article-title":"Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease","volume":"143","author":"Mahon","year":"2005","journal-title":"Ann Intern Med"},{"key":"2026080912175992400_euac030-B355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199201093260201","article-title":"The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy","volume":"326","author":"Michels","year":"1992","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B356","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ehf2.13100","article-title":"Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry","volume":"8","author":"Asselbergs","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026080912175992400_euac030-B357","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B358","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacbts.2021.06.001","article-title":"Myopathic cardiac genotypes increase risk for myocarditis","volume":"6","author":"Kontorovich","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"2026080912175992400_euac030-B359","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","article-title":"Reevaluating the genetic contribution of monogenic dilated cardiomyopathy","volume":"141","author":"Mazzarotto","year":"2020","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B360","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/heartjnl-2020-316658","article-title":"Considering complexity in the genetic evaluation of dilated cardiomyopathy","volume":"107","author":"Jordan","year":"2021","journal-title":"Heart"},{"key":"2026080912175992400_euac030-B361","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/eurheartj\/ehab030","article-title":"Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23","volume":"42","author":"Garnier","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B362","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/eurheartj\/ehv122","article-title":"The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human Genetics","volume":"36","author":"Mogensen","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B363","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.hlc.2019.11.018","article-title":"Familial dilated cardiomyopathy","volume":"29","author":"Peters","year":"2020","journal-title":"Heart Lung Circ"},{"key":"2026080912175992400_euac030-B364","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B365","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B366","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.rbmo.2011.12.009","article-title":"PGD for inherited cardiac diseases","volume":"24","author":"Kuliev","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2026080912175992400_euac030-B367","doi-asserted-by":"crossref","first-page":"e001631","DOI":"10.1161\/CIRCGENETICS.116.001631","article-title":"Lamin A\/C-related cardiac disease: late onset with a variable and mild phenotype in a large cohort of patients with the lamin A\/C p.(Arg331Gln) founder mutation","volume":"10","author":"Hoorntje","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B368","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","article-title":"Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias","volume":"39","author":"Verdonschot","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B369","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B370","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B371","doi-asserted-by":"crossref","first-page":"e002467","DOI":"10.1161\/CIRCGEN.119.002467","article-title":"Arrhythmogenic right ventricular cardiomyopathy-associated desmosomal variants are rarely de novo","volume":"12","author":"Van Lint","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B372","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","article-title":"Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria","volume":"319","author":"Corrado","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026080912175992400_euac030-B373","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B374","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B375","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/eurheartj\/ehz669","article-title":"Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis","volume":"41","author":"Corrado","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B376","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/europace\/euq104","article-title":"Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: spectrum of mutations and clinical impact in practice","volume":"12","author":"Fressart","year":"2010","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B377","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080912175992400_euac030-B378","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0004.2012.01919.x","article-title":"The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43","volume":"83","author":"Hodgkinson","year":"2013","journal-title":"Clin Genet"},{"key":"2026080912175992400_euac030-B379","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/hmg\/10.3.189","article-title":"Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)","volume":"10","author":"Tiso","year":"2001","journal-title":"Hum Mol Genet"},{"key":"2026080912175992400_euac030-B380","first-page":"857","article-title":"The novel desmin variant p.Leu115Ile is associated with a unique form of biventricular Arrhythmogenic Cardiomyopathy","volume":"37","author":"Protonotarios","year":"2021","journal-title":"Can J Cardiol"},{"key":"2026080912175992400_euac030-B381","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/CIRCULATIONAHA.117.028719","article-title":"Novel desmin mutation p.Glu401Asp impairs filament formation, disrupts cell membrane integrity, and causes severe arrhythmogenic left ventricular cardiomyopathy\/dysplasia","volume":"137","author":"Berm\u00fadez-Jim\u00e9nez","year":"2018","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B382","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/med-2020-0150","article-title":"Clinical impact of post-mortem genetic testing in cardiac death and cardiomyopathy","volume":"15","author":"Marey","year":"2020","journal-title":"Open Med (Wars)"},{"key":"2026080912175992400_euac030-B383","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B384","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/CIRCULATIONAHA.110.976936","article-title":"Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria","volume":"123","author":"Quarta","year":"2011","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B385","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/eurheartj\/ehaa141","article-title":"The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy","volume":"41","author":"James","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B386","doi-asserted-by":"crossref","first-page":"e003097","DOI":"10.1161\/CIRCGEN.120.003097","article-title":"Cadherin 2-related arrhythmogenic cardiomyopathy: prevalence and clinical features","volume":"14","author":"Ghidoni","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B387","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41439-020-00120-y","article-title":"Genetic architecture of left ventricular noncompaction in adults","volume":"7","author":"Ross","year":"2020","journal-title":"Hum Genome Var"},{"key":"2026080912175992400_euac030-B388","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B389","doi-asserted-by":"crossref","first-page":"e008509","DOI":"10.1161\/CIRCEP.120.008509","article-title":"Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration","volume":"14","author":"Cadrin-Tourigny","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B390","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B391","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B392","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B393","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hrthm.2015.08.035","article-title":"Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers","volume":"13","author":"Sawant","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B394","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jacc.2017.12.019","article-title":"Genetics, clinical features, and long-term\u00a0outcome of noncompaction\u00a0cardiomyopathy","volume":"71","author":"Van Waning","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B395","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2013.02.004","article-title":"Do mitochondria contribute to left ventricular non-compaction cardiomyopathy? New findings from myocardium of patients with left ventricular non-compaction cardiomyopathy","volume":"109","author":"Liu","year":"2013","journal-title":"Mol Genet Metab"},{"key":"2026080912175992400_euac030-B396","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/cge.13484","article-title":"Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity","volume":"95","author":"Richard","year":"2019","journal-title":"Clin Genet"},{"key":"2026080912175992400_euac030-B397","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41431-018-0303-3","article-title":"Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants","volume":"27","author":"Vanlerberghe","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"2026080912175992400_euac030-B398","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jacc.2016.08.064","article-title":"Cardiac phenotype and long-term follow-up of patients with mutations in NKX2-5 gene","volume":"68","author":"Maury","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B399","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.hrcr.2017.12.002","article-title":"Holt-Oram syndrome in two families diagnosed with left ventricular noncompaction and conduction disease","volume":"4","author":"Ross","year":"2018","journal-title":"HeartRhythm Case Rep"},{"key":"2026080912175992400_euac030-B400","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2020.12.017","article-title":"Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults","volume":"328","author":"Femia","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026080912175992400_euac030-B401","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41436-020-01049-x","article-title":"Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies","volume":"23","author":"Mazzarotto","year":"2021","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B402","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jamacardio.2018.2465","article-title":"Clinical and genetic complexities of left ventricular noncompaction: preventing overdiagnosis in a disease we do not understand","volume":"3","author":"Ross","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026080912175992400_euac030-B403","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/eurheartj\/ehz317","article-title":"A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults","volume":"41","author":"Ross","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B404","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1016\/j.jacc.2016.04.024","article-title":"Idiopathic restrictive cardiomyopathy is\u00a0primarily a genetic\u00a0disease","volume":"67","author":"Gallego-Delgado","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B405","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/hrt.2007.134684","article-title":"Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes","volume":"94","author":"Kaski","year":"2008","journal-title":"Heart"},{"key":"2026080912175992400_euac030-B406","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.hfc.2009.11.005","article-title":"Genetics of restrictive cardiomyopathy","volume":"6","author":"Sen-Chowdhry","year":"2010","journal-title":"Heart Fail Clin"},{"key":"2026080912175992400_euac030-B407","first-page":"39","article-title":"Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction","volume":"8","author":"Ton","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"key":"2026080912175992400_euac030-B408","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2016.200","article-title":"Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans","volume":"19","author":"Buxbaum","year":"2017","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B409","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","article-title":"Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease","volume":"52","author":"Germain","year":"2015","journal-title":"J Med Genet"},{"key":"2026080912175992400_euac030-B410","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/eurheartj\/ehz298","article-title":"Treatment of cardiac transthyretin amyloidosis: an update","volume":"40","author":"Emdin","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B411","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B412","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/hrt.2006.099598","article-title":"Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death","volume":"93","author":"Behr","year":"2007","journal-title":"Heart"},{"key":"2026080912175992400_euac030-B413","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41431-019-0500-8","article-title":"The yield of postmortem genetic testing in sudden death cases with structural findings at autopsy","volume":"28","author":"Lahrouchi","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"2026080912175992400_euac030-B414","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/europace\/eut329","article-title":"The importance of specialist cardiac histopathological examination in the investigation of young sudden cardiac deaths","volume":"16","author":"de Noronha","year":"2014","journal-title":"Europace"},{"key":"2026080912175992400_euac030-B415","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mayocp.2012.02.017","article-title":"Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing","volume":"87","author":"Tester","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"2026080912175992400_euac030-B416","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B417","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jacc.2017.02.046","article-title":"Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome","volume":"69","author":"Lahrouchi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B418","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2020.09.031","article-title":"\"Concealed cardiomyopathy\" as a cause of previously unexplained sudden cardiac arrest","volume":"324","author":"Isbister","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026080912175992400_euac030-B419","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCGENETICS.115.001370","article-title":"Whole-exome molecular autopsy after exertion-related sudden unexplained death in the young","volume":"9","author":"Anderson","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B420","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/CIRCULATIONAHA.117.031053","article-title":"Importance of variant interpretation in whole-exome molecular autopsy: population-based case series","volume":"137","author":"Shanks","year":"2018","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B421","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac145","article-title":"Importance of genetic testing in unexplained cardiac arrest","author":"Grondin","year":"2022","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B422","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","article-title":"Sudden cardiac death","volume":"98","author":"Zipes","year":"1998","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B423","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.CIR.95.1.265","article-title":"Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States","volume":"95","year":"1997","journal-title":"Circulation"},{"key":"2026080912175992400_euac030-B424","doi-asserted-by":"crossref","first-page":"e001686","DOI":"10.1161\/CIRCGENETICS.116.001686","article-title":"Genetic testing in the evaluation of unexplained cardiac arrest: from the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry)","volume":"10","author":"Mellor","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B425","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.amjcard.2019.02.061","article-title":"Usefulness of genetic testing in sudden cardiac arrest survivors with or without previous clinical evidence of heart disease","volume":"123","author":"Asatryan","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026080912175992400_euac030-B426","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.hrthm.2017.01.010","article-title":"Next-generation sequencing of a large gene panel in patients initially diagnosed with idiopathic ventricular fibrillation","volume":"14","author":"Visser","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B427","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.hrthm.2013.11.008","article-title":"Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia","volume":"11","author":"Matassini","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B428","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ajhg.2009.02.009","article-title":"Haplotype-sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation","volume":"84","author":"Alders","year":"2009","journal-title":"Am J Hum Genet"},{"key":"2026080912175992400_euac030-B429","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.hrthm.2016.10.015","article-title":"A type 2 ryanodine receptor variant associated with reduced Ca(2+) release and short-coupled torsades de pointes ventricular arrhythmia","volume":"14","author":"Fujii","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026080912175992400_euac030-B430","doi-asserted-by":"crossref","first-page":"e010013","DOI":"10.1161\/CIRCEP.121.010013","article-title":"Human RyR2 (Ryanodine Receptor 2) loss-of-function mutations: clinical phenotypes and in vitro characterization","volume":"14","author":"Li","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080912175992400_euac030-B431","first-page":"1","article-title":"The diagnostic yield of prenatal genetic technologies in congenital heart disease: a prospective cohort study","author":"Mone","year":"2021","journal-title":"Fetal Diagn Ther"},{"key":"2026080912175992400_euac030-B432","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/uog.23532","article-title":"Comprehensive evaluation of genetic variants in fetuses with congenital heart defect using chromosomal microarray analysis and exome sequencing","volume":"58","author":"Qiao","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026080912175992400_euac030-B433","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/uog.22072","article-title":"COngenital heart disease and the Diagnostic yield with Exome sequencing (CODE) study: prospective cohort study and systematic review","volume":"57","author":"Mone","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026080912175992400_euac030-B434","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/ajmg.a.38309","article-title":"Assessment of large copy number variants in patients with apparently isolated congenital left-sided cardiac lesions reveals clinically relevant genomic events","volume":"173","author":"Hanchard","year":"2017","journal-title":"Am J Med Genet A"},{"key":"2026080912175992400_euac030-B435","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mgg3.357","article-title":"Experience with genomic sequencing in pediatric patients with congenital cardiac defects in a large community hospital","volume":"6","author":"Hauser","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"2026080912175992400_euac030-B436","doi-asserted-by":"crossref","first-page":"e00796","DOI":"10.1002\/mgg3.796","article-title":"Targeted gene panel sequencing for the rapid diagnosis of acutely ill infants","volume":"7","author":"Brunelli","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2026080912175992400_euac030-B437","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/eurheartj\/ehl560","article-title":"Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients","volume":"28","author":"Thienpont","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080912175992400_euac030-B438","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/ng.3970","article-title":"Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands","volume":"49","author":"Jin","year":"2017","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B439","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.aac9396","article-title":"De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies","volume":"350","author":"Homsy","year":"2015","journal-title":"Science"},{"key":"2026080912175992400_euac030-B440","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng.3627","article-title":"Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing","volume":"48","author":"Sifrim","year":"2016","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B441","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41436-018-0296-x","article-title":"Identification of clinically actionable variants from genome sequencing of families with congenital heart disease","volume":"21","author":"Alankarage","year":"2019","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B442","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ajmg.a.37108","article-title":"The diagnostic value of next generation sequencing in familial nonsyndromic congenital heart defects","volume":"167a","author":"Jia","year":"2015","journal-title":"Am J Med Genet A"},{"key":"2026080912175992400_euac030-B443","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.jacc.2014.09.048","article-title":"Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease","volume":"64","author":"Blue","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B444","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCGENETICS.115.001324","article-title":"Utilization of whole exome sequencing to identify causative mutations in familial congenital heart disease","volume":"9","author":"LaHaye","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080912175992400_euac030-B445","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000331272","article-title":"Challenges of interpreting copy number variation in syndromic and non-syndromic congenital heart defects","volume":"135","author":"Breckpot","year":"2011","journal-title":"Cytogenet Genome Res"},{"key":"2026080912175992400_euac030-B446","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/humu.24132","article-title":"Next-generation sequencing in a series of 80 fetuses with complex cardiac malformations and\/or heterotaxy","volume":"41","author":"Liu","year":"2020","journal-title":"Hum Mutat"},{"key":"2026080912175992400_euac030-B447","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41431-018-0307-z","article-title":"Genetic architecture of laterality defects revealed by whole exome sequencing","volume":"27","author":"Li","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"2026080912175992400_euac030-B448","doi-asserted-by":"crossref","first-page":"00213","DOI":"10.1183\/23120541.00213-2020","article-title":"Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia","volume":"6","author":"Gileles-Hillel","year":"2020","journal-title":"ERJ Open Res"},{"key":"2026080912175992400_euac030-B449","doi-asserted-by":"crossref","first-page":"e002836","DOI":"10.1161\/CIRCGEN.119.002836","article-title":"De novo damaging variants, clinical phenotypes, and post-operative outcomes in congenital heart disease","volume":"13","author":"Boskovski","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B450","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/chd.12317","article-title":"Familial atrial septal defect and sudden cardiac death: identification of a novel NKX2-5 mutation and a review of the literature","volume":"11","author":"Elles\u00f8e","year":"2016","journal-title":"Congenit Heart Dis"},{"key":"2026080912175992400_euac030-B451","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0197-21","article-title":"Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family","volume":"15","author":"Li","year":"1997","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B452","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.hlc.2020.07.013","article-title":"Current practice of genetic testing and counselling in congenital heart disease: an Australian perspective","volume":"29","author":"Blue","year":"2020","journal-title":"Heart Lung Circ"},{"key":"2026080912175992400_euac030-B453","doi-asserted-by":"crossref","first-page":"640729","DOI":"10.3389\/fcvm.2021.640729","article-title":"Environmental risk factors and congenital heart disease: an umbrella review of 165 systematic reviews and meta-analyses with more than 120 million participants","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026080912175992400_euac030-B454","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1186\/1471-2164-15-1127","article-title":"Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield","volume":"15","author":"Geng","year":"2014","journal-title":"BMC Genomics"},{"key":"2026080912175992400_euac030-B455","doi-asserted-by":"crossref","first-page":"e001978","DOI":"10.1161\/CIRCGEN.117.001978","article-title":"A screening approach to identify clinically actionable variants causing congenital heart disease in exome data","volume":"11","author":"Szot","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B456","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s40142-014-0049-3","article-title":"Copy number variation in congenital heart defects","volume":"2","author":"Lander","year":"2014","journal-title":"Curr Genet Med Rep"},{"key":"2026080912175992400_euac030-B457","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0735-1097(16)30992-5","article-title":"Diagnostic exome sequencing in pediatric patients with congenital heart disease","volume":"67","author":"Powis","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B458","article-title":"A new era of genetic testing in congenital heart disease: a review","author":"Morrish","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"2026080912175992400_euac030-B459","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.siny.2017.10.001","article-title":"Ethical considerations in prenatal testing: genomic testing and medical uncertainty","volume":"23","author":"Richardson","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"key":"2026080912175992400_euac030-B460","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/aogs.13047","article-title":"Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population\u2014a systematic review and meta-analysis","volume":"96","author":"Iwarsson","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026080912175992400_euac030-B461","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/uog.18905","article-title":"First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial","volume":"51","author":"Kagan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026080912175992400_euac030-B462","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/pd.5800","article-title":"First-trimester screening based on cell-free DNA vs combined screening: a randomized clinical trial on women's experience","volume":"40","author":"Migliorini","year":"2020","journal-title":"Prenat Diagn"},{"key":"2026080912175992400_euac030-B463","doi-asserted-by":"crossref","first-page":"e006906","DOI":"10.1161\/JAHA.117.006906","article-title":"Advances in the understanding of the genetic determinants of congenital heart disease and their impact on clinical outcomes","volume":"7","author":"Russell","year":"2018","journal-title":"JAHA"},{"key":"2026080912175992400_euac030-B464","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.116.309140","article-title":"Genetics and genomics of congenital heart disease","volume":"120","author":"Zaidi","year":"2017","journal-title":"Circ Res"},{"key":"2026080912175992400_euac030-B465","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/pd.5449","article-title":"Chromosomal microarray analysis in fetuses with an isolated congenital heart defect: A retrospective, nationwide, multicenter study in France","volume":"39","author":"Hureaux","year":"2019","journal-title":"Prenat Diagn"},{"key":"2026080912175992400_euac030-B466","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/s41436-020-0791-8","article-title":"The prevalence of genetic diagnoses in fetuses with severe congenital heart defects","volume":"22","author":"van Nisselrooij","year":"2020","journal-title":"Genet Med"},{"key":"2026080912175992400_euac030-B467","doi-asserted-by":"crossref","first-page":"e000086","DOI":"10.1161\/HCG.0000000000000086","article-title":"Genetic testing for heritable cardiovascular diseases in pediatric patients: a scientific statement from the American Heart Association","volume":"14","author":"Landstrom","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2026080912175992400_euac030-B468","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"2026080912175992400_euac030-B469","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa0706728","article-title":"Polymorphisms associated with cholesterol and risk of cardiovascular events","volume":"358","author":"Kathiresan","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B470","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ng.327","article-title":"Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants","volume":"41","author":"Myocardial Infarction Genetics","year":"2009","journal-title":"Nat Genet"},{"key":"2026080912175992400_euac030-B471","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080912175992400_euac030-B472","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080912175992400_euac030-B473","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2019.21782","article-title":"Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease","volume":"323","author":"Mosley","year":"2020","journal-title":"JAMA"},{"key":"2026080912175992400_euac030-B474","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2019.22241","article-title":"Predictive accuracy of a polygenic risk score-enhanced prediction model vs a clinical risk score for coronary artery disease","volume":"323","author":"Elliott","year":"2020","journal-title":"JAMA"},{"key":"2026080912175992400_euac030-B475","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","author":"Mega","year":"2015","journal-title":"Lancet"},{"key":"2026080912175992400_euac030-B476","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2015.61","article-title":"Gene therapy to treat cardiac arrhythmias","volume":"12","author":"Bongianino","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026080912175992400_euac030-B477","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.gene.2014.07.043","article-title":"Endothelin 1 gene as a modifier in dilated cardiomyopathy","volume":"548","author":"Matsa","year":"2014","journal-title":"Gene"},{"key":"2026080912175992400_euac030-B478","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.1236921","article-title":"Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy","volume":"342","author":"Jiang","year":"2013","journal-title":"Science"},{"key":"2026080912175992400_euac030-B479","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2026080912175992400_euac030-B480","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/CIRCULATIONAHA.120.051836","article-title":"Suppression-replacement KCNQ1 gene therapy for type 1 long QT syndrome","volume":"143","author":"Dotzler","year":"2021","journal-title":"Circulation"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/24\/8\/1307\/60919274\/euac030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/24\/8\/1307\/60919274\/euac030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:19:04Z","timestamp":1786292344000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/24\/8\/1307\/6562982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":480,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euac030","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8]]},"published":{"date-parts":[[2022,4,4]]}}}